| Primary information |
|---|
| ID | antitb_1954, |
| Name | 28423019 |
| N-Terminal modification | Wollamide- B |
| C-Terminal Modification | ALlVNx |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | Third residue is D-leucine and x= ornithine |
| Chirality | Cyclic |
| Nature | 6 |
| Source | D |
| Origin | Cationic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
| Cell Line | MIC > 80 μM |
| Inhibition Concentration | In vitro |
| Sequence | 2017 |
| Cytotoxicity | HepG2 cell line |
| In vivo Model | NA |
| Lethal Dose | Cytoxic above > 100 μM |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | cell wall pore formation |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |